The fight for dominance between Regeneron and Bayer’s big blockbuster eye drug Eylea and Roche’s rival Vabysmo is playing out ...
German pharmaceutical giant Bayer released its ... innovators like Impli to explore the exciting frontiers of making health ...
The optimism is rooted in new launches, Stefan Oelrich, head of Bayer’s pharma division, said Tuesday at the J.P. Morgan Healthcare Conference. Besides label expansions for in-market products ...
Bayer expects its pharmaceutical business to return to growth in 2027, unit President Stefan Oelrich said Monday. The German conglomerate is planning to launch new therapies — one that treats a ...
Hosted on MSN1y
Bradley Williams joins Bayer Thai as managing director and leads pharmaceuticals divisionWith over 26 years of distinguished experience in the healthcare and pharmaceutical industry, Bradley's leadership will play a pivotal role in advancing Bayer's presence and growth in Thailand ...
Despite challenges in the Crop Science division, the strength of the Pharmaceuticals division and steady performance in Consumer Health are encouraging. Moreover, Bayer recently scored an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback